Zimmer Biomet Holdings, Inc. Share Price Today: Live Updates & Key Insights

Zimmer Biomet Holdings, Inc. share price today is $92.59, up -1.22%. The stock opened at $94 against the previous close of $93.73, with an intraday high of $95.275 and low of $92.46.

Zimmer Biomet Holdings, Inc. Share Price Chart

Zimmer Biomet Holdings, Inc.

us-stock
To Invest in {{usstockname}}
us-stock

Zimmer Biomet Holdings, Inc. Share Price Performance

$92.59 -0.0122(-1.22%) ZBH at 13 Mar 2026 04:00 PM Medical Devices
Lowest Today 92.46
Highest Today 95.275
Today’s Open 94
Prev. Close 93.73
52 Week High 113.56
52 Week Low 84.59
Day’s Range: Low 92.46 High 95.275
52-Week Range: Low 84.59 High 113.56
1 day return -
1 Week return -1.62
1 month return -3.94
3 month return +0.19
6 month return -8.24
1 year return -13.96
3 year return -25.46
5 year return -40.83
10 year return -

Zimmer Biomet Holdings, Inc. Institutional Holdings

Dodge & Cox 12.01

Vanguard Group Inc 12.00

BlackRock Inc 8.25

Dodge & Cox Stock I 7.95

T. Rowe Price Associates, Inc. 7.71

Harris Associates L.P. 6.27

State Street Corp 4.41

Capital Research & Mgmt Co - Division 3 3.86

Vanguard Total Stock Mkt Idx Inv 3.20

Oakmark Investor 2.91

Geode Capital Management, LLC 2.66

Vanguard 500 Index Investor 2.58

American Century Companies Inc 2.51

Franklin Resources Inc 2.39

Vanguard Windsor II Inv 2.30

Vanguard Mid Cap Index Institutional 2.19

PRIMECAP Management Company 2.04

American Funds Washington Mutual A 1.98

Capital Group Wash Mutual Invtrs Comp 1.98

Ameriprise Financial Inc 1.94

Van Eck Associates Corporation 1.78

VanEck Morningstar Wide Moat 1.66

VanEck Morningstar Wide Moat ETF 1.62

Amvescap Plc. 1.55

iShares Core S&P 500 ETF 1.29

Fidelity 500 Index 1.29

NORGES BANK 1.26

State Street® SPDR® S&P 500® ETF 1.20

T. Rowe Price US Lg-Cp Equity Inc Comp 1.18

T. Rowe Price US Mid-Cap Value Equity 1.15

Dimensional Fund Advisors, Inc. 1.12

T. Rowe Price Equity Income 1.10

Northern Trust Corp 1.08

Victory Capital Management Inc. 0.98

American Funds Fundamental Invs A 0.95

Capital Group Fundamental Invtrs Comp 0.95

Invesco S&P 500® Equal Weight ETF 0.94

Vanguard Value Index Inv 0.93

JPMorgan Chase & Co 0.91

Hotchkis & Wiley Capital Management LLC 0.88

Zimmer Biomet Holdings, Inc. Market Status

Strong Buy: 5

Buy: 6

Hold: 16

Sell: 1

Strong Sell: 1

Zimmer Biomet Holdings, Inc. Fundamentals

Market Cap 18575.56 M

PB Ratio 1.4442

PE Ratio 26.4028

Enterprise Value 25265.66 M

Total Assets 23091.70 M

Volume 3184555

Zimmer Biomet Holdings, Inc. Company Financials

Annual Revenue FY25:8231500000 8231.5M, FY24:2023200000 2023.2M, FY23:7279200000 7279.2M, FY22:6939900000 6939.9M, FY21:6827300000 6827.3M

Annual Profit FY25:5071900000 5071.9M, FY24:1278900000 1278.9M, FY23:5213900000 5213.9M, FY22:4920400000 4920.4M, FY21:4866900000 4866.9M

Annual Net worth FY25:705200000 705.2M, FY24:903800000 903.8M, FY23:474300000 474.3M, FY22:231400000 231.4M, FY21:401600000 401.6M

Quarterly Revenue Q4/2025:2243800000 2243.8M, Q3/2025:2001400000 2001.4M, Q2/2025:2077300000 2077.3M, Q1/2025:1909100000 1909.1M, Q3/2024:1824200000 1824.2M

Quarterly Profit Q4/2025:1451400000 1451.4M, Q3/2025:1442100000 1442.1M, Q2/2025:1485100000 1485.1M, Q1/2025:1359300000 1359.3M, Q3/2024:1285600000 1285.6M

Quarterly Net worth Q4/2025:139500000 139.5M, Q3/2025:230900000 230.9M, Q2/2025:152800000 152.8M, Q1/2025:182000000 182.0M, Q3/2024:249200000 249.2M

About Zimmer Biomet Holdings, Inc. & investment objective

Company Information Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Organisation Medical Devices

Employees 17000

Industry Medical Devices

CEO Mr. Ivan Tornos

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right